Lymphokines

DBCAT002874Pharmacologic class

Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. A DrugBank category of 9 drugs. 2 of them are approved.

Also known as: Lymphocyte Mediators · Mediators, Lymphocyte
Drugs: Aldesleukin
ALT-801
Bempegaldesleukin
Dialyzable leukocyte extract
Human interleukin-2
Interferon gamma-1b
Lorukafusp alfa
Teceleukin
Tucotuzumab celmoleukin

What you can answer from here — as of November 01, 2016

9DrugsEach linked to its full drug card

Listed above

13Drug targetsEvery drug–target pair in the class, with bond type

15Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Lymphokines share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account